SOLUTION NMR

NMR Experiment
Experiment Type Sample Contents Ionic Strength Solvent pH Pressure Temprature (K)
1 2D 1H-13C HSQC/HMQC .9 mM [U-99% 13C; U-99% 15N] AR55, 50 % [U-99% 2H] hexafluoroisopropanol, 1 mM DSS, 5 mM [U-99% 2H] DTT, 40 % H2O, 10 % [U-99% 2H] D2O, 50% Hexafluoroisopropanol/40% H2O /10% D2O ? 50% Hexafluoroisopropanol/40% H2O /10% D2O ? ? 310
2 3D HNCO .9 mM [U-99% 13C; U-99% 15N] AR55, 50 % [U-99% 2H] hexafluoroisopropanol, 1 mM DSS, 5 mM [U-99% 2H] DTT, 40 % H2O, 10 % [U-99% 2H] D2O, 50% Hexafluoroisopropanol/40% H2O /10% D2O ? 50% Hexafluoroisopropanol/40% H2O /10% D2O ? ? 310
3 HNcaCO (H[N[ca[CO]]]) .9 mM [U-99% 13C; U-99% 15N] AR55, 50 % [U-99% 2H] hexafluoroisopropanol, 1 mM DSS, 5 mM [U-99% 2H] DTT, 40 % H2O, 10 % [U-99% 2H] D2O, 50% Hexafluoroisopropanol/40% H2O /10% D2O ? 50% Hexafluoroisopropanol/40% H2O /10% D2O ? ? 310
4 3D HNCA .9 mM [U-99% 13C; U-99% 15N] AR55, 50 % [U-99% 2H] hexafluoroisopropanol, 1 mM DSS, 5 mM [U-99% 2H] DTT, 40 % H2O, 10 % [U-99% 2H] D2O, 50% Hexafluoroisopropanol/40% H2O /10% D2O ? 50% Hexafluoroisopropanol/40% H2O /10% D2O ? ? 310
5 HNcoCACB (H[N[co[{CA|ca[C]}]]]) .9 mM [U-99% 13C; U-99% 15N] AR55, 50 % [U-99% 2H] hexafluoroisopropanol, 1 mM DSS, 5 mM [U-99% 2H] DTT, 40 % H2O, 10 % [U-99% 2H] D2O, 50% Hexafluoroisopropanol/40% H2O /10% D2O ? 50% Hexafluoroisopropanol/40% H2O /10% D2O ? ? 310
6 3D HNCA .9 mM [U-99% 13C; U-99% 15N] AR55, 50 % [U-99% 2H] hexafluoroisopropanol, 1 mM DSS, 5 mM [U-99% 2H] DTT, 40 % H2O, 10 % [U-99% 2H] D2O, 50% Hexafluoroisopropanol/40% H2O /10% D2O ? 50% Hexafluoroisopropanol/40% H2O /10% D2O ? ? 310
7 3D HN(CO)CA .9 mM [U-99% 13C; U-99% 15N] AR55, 50 % [U-99% 2H] hexafluoroisopropanol, 1 mM DSS, 5 mM [U-99% 2H] DTT, 40 % H2O, 10 % [U-99% 2H] D2O, 50% Hexafluoroisopropanol/40% H2O /10% D2O ? 50% Hexafluoroisopropanol/40% H2O /10% D2O ? ? 310
8 3D 1H-15N TOCSY .9 mM [U-99% 13C; U-99% 15N] AR55, 50 % [U-99% 2H] hexafluoroisopropanol, 1 mM DSS, 5 mM [U-99% 2H] DTT, 40 % H2O, 10 % [U-99% 2H] D2O, 50% Hexafluoroisopropanol/40% H2O /10% D2O ? 50% Hexafluoroisopropanol/40% H2O /10% D2O ? ? 310
9 3D 1H-15N NOESY .9 mM [U-99% 13C; U-99% 15N] AR55, 50 % [U-99% 2H] hexafluoroisopropanol, 1 mM DSS, 5 mM [U-99% 2H] DTT, 40 % H2O, 10 % [U-99% 2H] D2O, 50% Hexafluoroisopropanol/40% H2O /10% D2O ? 50% Hexafluoroisopropanol/40% H2O /10% D2O ? ? 310
10 3D HCCH-TOCSY .9 mM [U-99% 13C; U-99% 15N] AR55, 50 % [U-99% 2H] hexafluoroisopropanol, 1 mM DSS, 5 mM [U-99% 2H] DTT, 40 % H2O, 10 % [U-99% 2H] D2O, 50% Hexafluoroisopropanol/40% H2O /10% D2O ? 50% Hexafluoroisopropanol/40% H2O /10% D2O ? ? 310
11 3D 1H-13C NOESY .9 mM [U-99% 13C; U-99% 15N] AR55, 50 % [U-99% 2H] hexafluoroisopropanol, 1 mM DSS, 5 mM [U-99% 2H] DTT, 40 % H2O, 10 % [U-99% 2H] D2O, 50% Hexafluoroisopropanol/40% H2O /10% D2O ? 50% Hexafluoroisopropanol/40% H2O /10% D2O ? ? 310
12 HSQC_NOESY_125ms_HSQC (h[C]_H[N].NOESY) .9 mM [U-99% 13C; U-99% 15N] AR55, 50 % [U-99% 2H] hexafluoroisopropanol, 1 mM DSS, 5 mM [U-99% 2H] DTT, 40 % H2O, 10 % [U-99% 2H] D2O, 50% Hexafluoroisopropanol/40% H2O /10% D2O ? 50% Hexafluoroisopropanol/40% H2O /10% D2O ? ? 310
13 15NHSQC .9 mM [U-99% 13C; U-99% 15N] AR55, 50 % [U-99% 2H] hexafluoroisopropanol, 1 mM DSS, 5 mM [U-99% 2H] DTT, 40 % H2O, 10 % [U-99% 2H] D2O, 50% Hexafluoroisopropanol/40% H2O /10% D2O ? 50% Hexafluoroisopropanol/40% H2O /10% D2O ? ? 310
NMR Spectrometer Information
Spectrometer Manufacturer Model Field Strength
1 Bruker AVANCE III 700
NMR Refinement
Method Details Software
simulated annealing, torsion angle dynamics ? 1
NMR Ensemble Information
Conformer Selection Criteria structures with the lowest energy
Conformers Calculated Total Number 100
Conformers Submitted Total Number 40
Representative Model 1 (extended conformation)
Computation: NMR Software
# Classification Version Software Name Author
1 chemical shift assignment 2.2 CcpNmr Analysis CCPN
2 peak picking 2.2 CcpNmr Analysis CCPN
3 processing ? NMRPipe Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4 structure solution ? X-PLOR NIH Schwieters, Kuszewski, Tjandra and Clore
5 refinement ? X-PLOR NIH Schwieters, Kuszewski, Tjandra and Clore